Cannabis withdrawal and manic episodes: Three cases of an unknown trigger for bipolar disorder

EV has received grants and served as consultant, advisor or CME speaker for the following entities (unrelated to the present work): AB-Biotics, Abbott, Allergan, Angelini, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, Janssen, Lundbeck, Otsuka, Sage, Sanofi-Aventis and Takeda. IP has received CME-related honoraria, or consulting fees from Janssen-Cilag, Lundbeck, Lundbeck/Otsuka, CASEN Recordati and Angelini, with no financial or other relationship relevant to the subject of this article. AGP has received CME-related honoraria or consulting fees from Angelini, Janssen-Cilag, Casen Recordati, Rovi, LCN and Lundbeck, and reports no financial or other relationship relevant to the subject of this article. PB has received CME-related honoraria from Lundbeck and reports no financial or other relationship relevant to the subject of this article. MV has received research grants from Eli Lilly & Company and has served as a speaker for Abbot, Bristol-Myers Squibb, GlaxoSmithKline, Janssen-Cilag and Lundbeck. The rest of the authors report no biomedical financial interests or potential conflicts of interest related to the present article. The data that support the findings of this study are available on request from the corresponding authors.